2 sources checked · 2 source groups included · 1h ago
Needs Review
Eli Lilly: Next-gen weight loss drug may be more effective than others
Eli Lilly says next-generation weight loss drug clears crucial obesity trial. “The highest dose of retatrutide helped patients lose 28.3% of their weight — or 70.3 pounds — on average over 80 weeks.”
0 Left1 Center1 Right
Needs review.This source map is too narrow, too early, or mixed-format to trust yet.
NEEDS REVIEW
As of May 21, 2026 at 7:51 PM, this is how Optics News reads the wording differences in this story.
What happenedEli Lilly's weight loss drug retatrutide helped nearly half of participants in a phase 3 trial to lose more than 30% of their weight after two years.
The headline splitRelated angle. The source map includes different article formats, so wording may reflect format as well as framing.
Can I trust it?Not yet. Article formats differ, so wording may reflect format as much as framing.
Wording differs, but the match is too narrow to read confidently yet.
WHAT EACH SIDE EMPHASIZED
Left / center-leftNo matching source in this bucket yet.
Optics keeps watching for pickup.
CenterEli Lilly: Next-gen weight loss drug may be more effective than others
UPI · Center · Wire story
Right / center-rightEli Lilly says next-generation weight loss drug clears crucial obesity trial. “The
Instapundit · Right · Opinion
Article formats differ across these sources, so wording may reflect format as well as framing.
AND ANOTHER ONE: Eli Lilly says next-generation weight loss drug clears crucial obesity trial. “The
anothernext-generationclears
Eli Lilly says next-generation weight loss drug clears crucial obesity trial. “The highest dose of retatrutide helped patients lose 28.3% of their weight — or 70.3 pounds — on average over...
